J-Pharma Co.,Ltd.

520A TSE Pharmaceuticals Pharmaceutical
TSE Growth
¥467.00
-9.32%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.09.
  • Current assets comfortably cover current liabilities (current ratio 12.57).

!Watch-points

  • Return on equity is on the lower side at -60.7%.
  • Return on capital employed is on the lower side at -84.6%.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
-2.19

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the market-value term.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap¥84億
Current Price¥ 467.00
High / Low¥ 809.00 / 260.00
Stock P/E-2.39
Book Value¥ 226.07
Dividend Yield0%
ROCE-84.64%
ROE-60.67%
Debt to Equity0.09
Current Ratio12.57
P/B Ratio2.2027574
EPS¥ -195.08
Educational data only. Not a recommendation to buy, sell or hold any security.